Your Messages Inbox
Most Viewed Abstracts
1. Report Shows Shift in Starting Salaries for Physicians 2. 2008 Exclusive Survey—Earnings: Good news for primary care income 3. Medicare pay-for-reporting effort draws fire from frustrated doctors 4. Debunking Myths in the US Healthcare System 5. Statins and cancer risk
Your Article Summary
See Latest ArticlesDynamic Contrast-Enhanced MRI for Prediction of Breast Cancer Response to Neoadjuvant Chemotherapy
American Journal of Roentgenology, 11/03/08
Loo CE et al. - Reduction of less than 25% in largest diameter of late enhancement during neoadjuvant chemotherapy shows the potential to predict residual tumor after therapy with high specificity.
Related Articles
Assessing the usefulness of a novel MRI-based breast density estimation algorithm in a cohort of women at high genetic risk of breast cancer: The UK MARIBS study
Breast Cancer Research, 11/17/09
Relevance Score: 94%
Detection of lymph nodes in pelvic malignancies with computed tomography and magnetic resonance imaging
Clinical Imaging, 10/16/09
Relevance Score: 92%
The impact of the relaxivity definition on the quantitative measurement of glycosaminoglycans in cartilage by the MRI dGEMRIC method
Magnetic Resonance in Medicine, 11/19/09
Relevance Score: 91%
Can breast MRI computer-aided detection improve radiologist accuracy for lesions detected at MRI screening and recommended for biopsy in a high-risk population
Clinical Radiology, 11/13/09
Relevance Score: 91%
Cranial ultrasound and MRI at term age in extremely preterm infants
BMJ - ADC - Fetal and Neonatal, 10/26/09
Relevance Score: 90%
Today in Chemotherapy/Oncology...keeping you current
Receive free subspecialty "5-minute updates" via email
GSK study showed targeted therapy combination achieved 14 month overall survival in patients with advanced breast cancer
GlaxoSmithKline, 12/15/09
Targeting cancer with phosphodiesterase inhibitors
Expert Opinion on Investigational Drugs, 12/15/09
Comparison of chemotherapy regimens for concurrent chemoradiotherapy in unresectable stage III non-small cell lung cancer
International Journal of Clinical Oncology, 12/15/09
Sponsor
Article Search
Sponsor
Sponsor